What Is an Opioid Overdose? Signs, Risks & Treatment

An opioid overdose happens when opioids overwhelm the body’s ability to breathe, slowing or stopping respiration to the point of oxygen deprivation and, without intervention, death. In 2024, opioids were involved in 54,045 overdose deaths in the United States, with synthetic opioids like fentanyl accounting for the vast majority. Understanding how overdoses happen, what they look like, and what reverses them can be the difference between life and death in an emergency.

How Opioids Shut Down Breathing

Opioids work by binding to receptors in the brain and body called mu-opioid receptors. These receptors are responsible for pain relief, but they’re also densely concentrated in the parts of the brainstem that control your automatic breathing rhythm. When too many opioids flood those receptors, they suppress the signals that tell your lungs to inhale.

Two brainstem regions are especially vulnerable. One is a small cluster of roughly 800 to 1,000 neurons on each side of the lower brainstem that generates your basic breathing rhythm. The other is a structure higher in the brainstem that coordinates the timing of each breath. At high opioid doses, this second region is particularly responsible for generating apnea, the complete cessation of breathing. When both areas are suppressed simultaneously, breathing can slow from a normal 12 to 20 breaths per minute down to 4 to 6 breaths per minute, or stop altogether. Without oxygen, the brain and heart begin to fail within minutes.

The Three Hallmark Signs

An opioid overdose produces a recognizable pattern known as the “opioid overdose triad”: pinpoint pupils, slowed or stopped breathing, and decreased consciousness. If someone is unresponsive and you can see that their pupils are tiny and their breathing is shallow, slow, or absent, opioids are the most likely cause.

Other signs fill out the picture. The person’s skin may turn pale, blue, or purple, especially around the lips and fingernails, signaling oxygen deprivation. Their limbs may go limp. Their skin often feels cold and clammy. Gurgling or snoring sounds from the mouth suggest the airway is partially blocked. Vomiting is common, which creates an additional choking risk when someone is unconscious. In some cases, particularly in young children, opioids can also trigger seizures.

Who Is Most at Risk

The single most dangerous scenario is resuming opioid use after a period of abstinence. When someone stops using opioids for days or weeks, their body’s tolerance drops rapidly. A dose that was once routine can now be fatal. This is why people leaving prison, completing detox programs, or stopping treatment face extremely high overdose rates, particularly in the first four weeks after release.

Other factors that raise the risk include:

  • Mixing substances. Combining opioids with alcohol, benzodiazepines (like Xanax or Valium), or barbiturates compounds the effect on breathing. Each substance suppresses respiration through its own pathway, and together they can overwhelm the body far faster than any one drug alone.
  • Injecting opioids. Injection delivers the full dose to the brain within seconds, leaving almost no time to recognize or respond to an overdose.
  • High prescribed doses. Patients taking the equivalent of 100 mg or more of morphine daily face elevated risk even under medical supervision.
  • Underlying health conditions. Lung disease, liver disease, HIV, and mental health conditions all increase vulnerability.
  • Unsupervised use of prescription opioids. Taking someone else’s medication or using higher doses than prescribed removes the safety checks built into medical monitoring.

Why Fentanyl Changed the Equation

Fentanyl is roughly 100 times more potent than morphine by weight. Just 0.1 mg of fentanyl (100 micrograms, an amount barely visible to the naked eye) produces the same pain-relieving effect as 10 mg of intravenous morphine. This extreme potency means the margin between a dose that gets someone high and a dose that stops their breathing is razor thin.

Illicitly manufactured fentanyl is now the dominant driver of overdose deaths. In 2024, synthetic opioids other than methadone (a category dominated by fentanyl and its analogs) killed 47,735 people in the U.S. The drug is often mixed into heroin, pressed into counterfeit pills, or combined with stimulants, meaning people sometimes consume it without knowing. Newer adulterants like xylazine, a veterinary sedative increasingly found alongside fentanyl, can worsen oxygen deprivation and make overdoses harder to reverse.

How Naloxone Reverses an Overdose

Naloxone (sold under the brand name Narcan, among others) is an opioid antagonist, meaning it competes with opioids for the same receptors in the brain. It has a stronger affinity for those receptors than most opioids do, so when it enters the bloodstream, it physically displaces the opioid molecules and temporarily restores normal breathing. It works within minutes when given as a nasal spray or injection.

The critical limitation is duration. Naloxone’s effects last only 30 to 80 minutes, while many opioids, especially long-acting formulations or large doses of fentanyl, remain active in the body for hours. This means a person can slip back into overdose after the naloxone wears off. Anyone who receives naloxone needs to be monitored for 6 to 12 hours afterward to ensure the overdose does not return.

Naloxone is available without a prescription at most pharmacies in the U.S. and is carried by many first responders. If you suspect someone is overdosing, administer naloxone, call 911, and place them on their side to prevent choking on vomit. A second dose may be needed if breathing doesn’t improve within a few minutes.

What Happens During an Overdose

The speed of onset depends on how the opioid enters the body. Injected or smoked opioids can cause overdose symptoms within seconds to minutes. Swallowed pills, particularly extended-release formulations, may take longer to peak but can produce a prolonged overdose that’s harder to manage.

The progression typically follows a pattern. Early signs include extreme drowsiness, slurred speech, and nausea. As the opioid level rises, the person becomes increasingly difficult to rouse. Breathing slows and becomes shallow. The skin changes color as oxygen levels drop. Without intervention, breathing can stop entirely, followed by cardiac arrest. The gurgling or snoring sounds that sometimes accompany an overdose are not signs of sleep. They indicate the person’s airway is compromised and they need help immediately.

Surviving an Overdose Isn’t the End

Non-fatal overdoses are not harmless events. The core danger is the period of oxygen deprivation the brain endures while breathing is suppressed. Even a few minutes of significantly reduced oxygen can cause hypoxic brain injury, damage to brain tissue from lack of oxygen.

Research has linked repeated non-fatal overdoses to injury in the hippocampus, the brain region critical for forming new memories. This may contribute to a condition called opioid-associated amnestic syndrome, where people develop significant memory problems after multiple overdoses. Studies have also found elevated levels of a protein called tau, associated with neurodegenerative diseases, in the brains of people who’ve experienced overdose-related oxygen deprivation. The combination of fentanyl with xylazine appears to worsen these outcomes by deepening and prolonging oxygen loss.

These findings mean that each non-fatal overdose carries the potential for cumulative, lasting neurological damage, even when the person appears to recover fully in the short term.

The Current Scale of the Crisis

In 2024, 79,384 people in the United States died from drug overdoses overall, with opioids involved in about two-thirds of those deaths. There is, however, a notable shift: overdose death rates declined across every opioid category between 2023 and 2024. Synthetic opioid deaths dropped 35.6%, the largest decrease recorded. The age-adjusted rate for synthetic opioid deaths fell from 22.2 per 100,000 people to 14.3. Whether this decline reflects expanded naloxone access, changes in drug supply, or other factors is still being sorted out, but it represents the first sustained improvement after years of escalation.